buthionine sulfoximine has been researched along with Shock, Septic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuzzocrea, S; O'Connor, M; Salzman, AL; Szabó, C; Zingarelli, B | 1 |
| Kang, KW; Kim, ND; Pak, YM | 1 |
| Barke, R; Harty, JT; Humphrey, E; Keller, GA; Simmons, RL | 1 |
3 other study(ies) available for buthionine sulfoximine and Shock, Septic
| Article | Year |
|---|---|
Effect of L-buthionine-(S,R)-sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite- and endotoxic shock-induced vascular failure.
Topics: Animals; Aorta, Thoracic; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Humans; In Vitro Techniques; Muscle Contraction; Nitrates; Nitric Oxide Synthase; Rats; Shock, Septic | 1998 |
Diethylmaleate and buthionine sulfoximine, glutathione-depleting agents, differentially inhibit expression of inducible nitric oxide synthase in endotoxemic mice.
Topics: Animals; Buthionine Sulfoximine; Gene Expression Regulation, Enzymologic; Glutathione; Interleukin-1; Lipopolysaccharides; Liver; Macrophages; Male; Maleates; Mice; Mice, Inbred ICR; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Reverse Transcriptase Polymerase Chain Reaction; Shock, Septic; Transcription, Genetic; Tumor Necrosis Factor-alpha | 1999 |
Decreased hepatic glutathione levels in septic shock. Predisposition of hepatocytes to oxidative stress: an experimental approach.
Topics: Animals; Buthionine Sulfoximine; Cells, Cultured; Escherichia coli Infections; Glutathione; Hydrogen Peroxide; Liver; Liver Function Tests; Methionine Sulfoximine; Multiple Organ Failure; Oxidation-Reduction; Protein Biosynthesis; Sheep; Shock, Septic | 1985 |